Student Recognized For Investigations Into The Potential Use Of Bacteriophage Coatings For The Prevention Of Microbial Colonisation On Medical Devices

Oxoid, a world-leading microbiology brand, is pleased to award the Oxoid Prize for the Best Project in Microbiology (2008) at the University of Brighton School of Pharmacy and Biomolecular Sciences to Niamh Kilbride for her investigations into the potential use of bacteriophage coatings for the prevention of microbial colonisation on medical devices.


In her research project, Niamh investigated several different methods for the immobilisation of phage K, with a view to developing a coating that would be effective against Staphylococcus aureus NCTC 10788. She studied the retention of the bacteriophage when dried onto the surface of untreated and silanised glass. She then incorporated the bacteriophage into a hydrogel coating and investigated whether the coating was effective at preventing or inhibiting the growth of bacteria on its surface.


Niamh concluded that it is possible to create a bacteriophage coating that can prevent microbial colonisation at sufficiently high concentrations of bacteriophage. She also concluded that the development of a suitable bacteriophage coating could potentially reduce and prevent the growth of bacteria in vivo.


Alison Smith, pharmaceutical microbiology manager, Oxoid, commented, "We are delighted to recognise this excellent research project. Pharmaceutical microbiologists worldwide are involved in the development and testing of new antimicrobials to fight hospital-acquired infections associated with indwelling medical devices, such as catheters. As a world-leading microbiology brand, we are keen to promote microbiologists like Niamh whose research may hold the answers for the prevention of such infections."



Niamh was presented with a framed certificate and a cheque for ВЈ150 prior to the graduation ceremonies at the University.


For further information about Oxoid products for clinical and industrial use, visit oxoid.


Oxoid is part of Thermo Fisher Scientific Inc., the world leader in serving science.


About Thermo Fisher Scientific



Thermo Fisher Scientific Inc. (NYSE: TMO) is the world leader in serving science, enabling our customers to make the world healthier, cleaner and safer. With annual revenues of $10 billion, we have more than 30,000 employees and serve over 350,000 customers within pharmaceutical and biotech companies, hospitals and clinical diagnostic labs, universities, research institutions and government agencies, as well as environmental and industrial process control settings. Serving customers through two premier brands, Thermo Scientific and Fisher Scientific, we help solve analytical challenges from routine testing to complex research and discovery. Thermo Scientific offers customers a complete range of high-end analytical instruments as well as laboratory equipment, software, services, consumables and reagents to enable integrated laboratory workflow solutions. Fisher Scientific provides a complete portfolio of laboratory equipment, chemicals, supplies and services used in healthcare, scientific research, safety and education. Together, we offer the most convenient purchasing options to customers and continuously advance our technologies to accelerate the pace of scientific discovery, enhance value for customers and fuel growth for shareholders and employees alike.

Thermo Fisher Scientific